George F. Heinrich
Chief Executive Officer at Foundation Venture Capital Group LLC
Profile
George F.
Heinrich is currently the Vice Chairman & Chief Executive Officer at Foundation Venture Capital Group LLC, the Vice Chairman & Chief Executive Officer at New Jersey Health Foundation, Inc., and a Director at Kayothera, Inc. He previously worked as a Director at Snowdon, Inc. He completed his undergraduate degree at Cornell University and obtained a doctorate from New Jersey Medical School.
George F. Heinrich active positions
Companies | Position | Start |
---|---|---|
Foundation Venture Capital Group LLC
Foundation Venture Capital Group LLC Investment ManagersFinance Foundation Venture Capital Group LLC (Foundation Venture) is a venture capital firm headquartered in Princeton, New Jersey. Founded in 2006, the firm is the equity investment arm of New Jersey Health Foundation Inc. | Chief Executive Officer | - |
New Jersey Health Foundation, Inc. | Chief Executive Officer | - |
Kayothera, Inc.
Kayothera, Inc. BiotechnologyHealth Technology Kayothera, Inc. operates as an early-stage therapeutics company. The firm develops therapies to treat late-stage and metastatic cancers, including breast, lung, pancreatic, colorectal, brain, and kidney cancers. The company was founded by Yibin Kang and Mark Esposito and is headquartered in Princeton, NJ. | Director/Board Member | - |
Former positions of George F. Heinrich
Companies | Position | End |
---|---|---|
Snowdon, Inc.
Snowdon, Inc. Pharmaceuticals: MajorHealth Technology Snowdon, Inc. operates as a drug discovery and development company. The firm creates and distributes computational tools and techniques for the life sciences including drug discovery and development, safety, toxicity assessment and environmental and toxicological surveillance. It provides a solution to the problems of efficiency and productivity in drug discovery by integrating an array of advanced tools with proprietary information technology to more efficiently discover new drugs and harness the flood of new disease-related protein targets presented by genomics. The company was founded by William J. Welsh and Susan M. Welsh in 2007 and is headquartered in Princeton, NJ. | Director/Board Member | - |
Training of George F. Heinrich
New Jersey Medical School | Doctorate Degree |
Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Foundation Venture Capital Group LLC
Foundation Venture Capital Group LLC Investment ManagersFinance Foundation Venture Capital Group LLC (Foundation Venture) is a venture capital firm headquartered in Princeton, New Jersey. Founded in 2006, the firm is the equity investment arm of New Jersey Health Foundation Inc. | Finance |
New Jersey Health Foundation, Inc. | Finance |
Snowdon, Inc.
Snowdon, Inc. Pharmaceuticals: MajorHealth Technology Snowdon, Inc. operates as a drug discovery and development company. The firm creates and distributes computational tools and techniques for the life sciences including drug discovery and development, safety, toxicity assessment and environmental and toxicological surveillance. It provides a solution to the problems of efficiency and productivity in drug discovery by integrating an array of advanced tools with proprietary information technology to more efficiently discover new drugs and harness the flood of new disease-related protein targets presented by genomics. The company was founded by William J. Welsh and Susan M. Welsh in 2007 and is headquartered in Princeton, NJ. | Health Technology |
Kayothera, Inc.
Kayothera, Inc. BiotechnologyHealth Technology Kayothera, Inc. operates as an early-stage therapeutics company. The firm develops therapies to treat late-stage and metastatic cancers, including breast, lung, pancreatic, colorectal, brain, and kidney cancers. The company was founded by Yibin Kang and Mark Esposito and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- George F. Heinrich